Low sensitivity to dual MEK/Bcl‐2 inhibition observed in some cell lines, particularly those of MCL origin, could be explained by high expression levels of the antiapoptotic Bcl‐2 family proteins Mcl‐1 or Bcl‐xL. Here, BCL2L1 is linked to mantle cell lymphoma.